STIM:NASDAQ
Neuronetics Inc
$3.04
arrow_upward
+3.75%(+0.11) 1D
$3.03
arrow_downward
-0.33% (-0.0100)bedtimeAfter hours
Closed: Sep 9, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for STIM...
Open
$2.91
High
$3.12
Low
$2.85
Mkt. cap
231.64M
Avg. vol.
2.35M
Volume
1.42M
52-wk high
$3.71
52-wk low
$0.80
EPS
-$0.44
Beta
1.16
Shares outstanding
76.20M
No. of employees
658
Open
$2.91
High
$3.12
Low
$2.85
Mkt. cap
231.64M
Avg. vol.
2.35M
Volume
1.42M
52-wk high
$3.71
52-wk low
$0.80
EPS
-$0.44
Beta
1.16
Shares outstanding
76.20M
No. of employees
658
News stories
From web sources and news partners
Stock Titan
·
1 day ago
A magnetic brain-treatment system links to patient records for the first time
Profile
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device."
They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head. Wikipedia
About Neuronetics Inc
CEO-
Employees658
Founded2003
HeadquartersMalvern, Pennsylvania, United States
SectorMedical device
Websiteneurostar.com